...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Liquidity
4
Jan 21, 2016 06:56PM
5
Jan 21, 2016 07:20PM

Thanks KBC.

I'm really hoping you are right and that it is an urgent issue for Don.

By the way with my little thought experiment re Dragons Den and Shark Tank I must say that Resverlogix has been attracting capital consistently for over 15 years (I believe because of the science) and in this regard RVX has been far more successful than most of the Dragons and Sharks. Anyway, it was just a bit of fun!

Beautiful day in Muskoka and I'm headed out for an LSJ.

GLTA

Toinv

1
Jan 22, 2016 05:05PM
4
Jan 22, 2016 05:36PM
4
Jan 22, 2016 06:36PM
4
Jan 24, 2016 11:53AM
5
Jan 24, 2016 12:49PM
2
Jan 24, 2016 07:00PM
Share
New Message
Please login to post a reply